{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:00:13Z","timestamp":1778101213069,"version":"3.51.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Center for Emerging, Zoonotic, and Arthropod-borne Pathogens"},{"DOI":"10.13039\/100007263","name":"Virginia Tech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The rapid occurrence of gonococcal resistance to all classes of antibiotics could lead to untreatable gonorrhea. Thus, development of novel anti-Neisseria gonorrhoeae drugs is urgently needed. Neisseria gonorrhoeae FA1090 is the most used in gonococcal infection mouse models because of its natural resistance to streptomycin. Streptomycin inhibits the urogenital commensal flora that permits gonococcal colonization. However, this strain is drug-susceptible and cannot be used to investigate the efficacy of novel agents against multidrug-resistant N. gonorrhoeae. Hence, to test the in vivo efficacy of new therapeutics against N. gonorrhoeae resistant to the frontline antibiotics, azithromycin, or ceftriaxone, we constructed streptomycin-resistant mutants of N. gonorrhoeae CDC-181 (azithromycin-resistant) and WHO-X (ceftriaxone-resistant). We identified the inoculum size needed to successfully colonize mice. Both mutants, CDC-181-rpsLA128G and WHO-X-rpsLA128G, colonized the genital tract of mice for 14 days with 100% colonization observed for at least 7 days. CDC-181-rpsLA128G demonstrated better colonization of the murine genital tract compared to WHO-X-rpsLA128G. Lower inoculum of WHO-X-rpsLA128G (105 and 106 CFU) colonized mice better than higher inoculum. Overall, our results indicate that CDC-181-rpsLA128G and WHO-X-rpsLA128G can colonize the lower genital tract of mice and are suitable to be used in mouse models to investigate the efficacy of antigonococcal agents.<\/jats:p>","DOI":"10.1093\/femspd\/ftad030","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:47:40Z","timestamp":1697590060000},"source":"Crossref","is-referenced-by-count":5,"title":["Colonization efficiency of multidrug-resistant <i>Neisseria gonorrhoeae<\/i> in a female mouse model"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-3610","authenticated-orcid":false,"given":"Babatomiwa","family":"Kikiowo","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University , 205 Duck Pond Drive, Blacksburg, VA 24061 , United States"},{"name":"Center for One Health Research, Virginia Polytechnic Institute and State University , 1410 Prices Fork Rd, Blacksburg, VA 24060 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2562-1810","authenticated-orcid":false,"given":"Aloka B","family":"Bandara","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University , 205 Duck Pond Drive, Blacksburg, VA 24061 , United States"},{"name":"Center for One Health Research, Virginia Polytechnic Institute and State University , 1410 Prices Fork Rd, Blacksburg, VA 24060 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1730-4150","authenticated-orcid":false,"given":"Nader S","family":"Abutaleb","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University , 205 Duck Pond Drive, Blacksburg, VA 24061 , United States"},{"name":"Center for One Health Research, Virginia Polytechnic Institute and State University , 1410 Prices Fork Rd, Blacksburg, VA 24060 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-0458","authenticated-orcid":false,"given":"Mohamed N","family":"Seleem","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University , 205 Duck Pond Drive, Blacksburg, VA 24061 , United States"},{"name":"Center for One Health Research, Virginia Polytechnic Institute and State University , 1410 Prices Fork Rd, Blacksburg, VA 24060 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"2023110918362177000_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14756366.2021.1991336","article-title":"Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae","volume":"37","author":"Abutaleb","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2023110918362177000_bib5","doi-asserted-by":"crossref","first-page":"105454","DOI":"10.1016\/j.micpath.2022.105454","article-title":"In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection","volume":"164","author":"Abutaleb","year":"2022","journal-title":"Microb Pathog"},{"key":"2023110918362177000_bib6","doi-asserted-by":"crossref","first-page":"e01225","DOI":"10.1128\/AAC.01225-19","article-title":"Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae","volume":"63","author":"Alhashimi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110918362177000_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection","volume":"366","author":"Bolan","year":"2012","journal-title":"N Engl J Med"},{"key":"2023110918362177000_bib8","doi-asserted-by":"crossref","first-page":"e00325","DOI":"10.1128\/AAC.00325-18","article-title":"Aminomethyl spectinomycins as therapeutics for drug-resistant gonorrhea and chlamydia coinfections","volume":"62","author":"Butler","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110918362177000_bib11","article-title":"Antibiotic resistance threats in the United States","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"2023110918362177000_bib3","article-title":"Gonorrhea","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2023110918362177000_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/169.3.532","article-title":"Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development","volume":"169","author":"Cohen","year":"1994","journal-title":"J Infect Dis"},{"key":"2023110918362177000_bib10","doi-asserted-by":"crossref","first-page":"e01644","DOI":"10.1128\/AAC.01644-18","article-title":"Pharmacokinetic data are predictive of in vivo efficacy for cefixime and ceftriaxone against susceptible and resistant Neisseria gonorrhoeae strains in the gonorrhea mouse model","volume":"63","author":"Connolly","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110918362177000_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2958.1998.00710.x","article-title":"The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers","volume":"27","author":"Cornelissen","year":"1998","journal-title":"Mol Microbiol"},{"key":"2023110918362177000_bib13","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's treatment guidelines for gonococcal infection, 2020","volume":"69","author":"Cyr","year":"2020","journal-title":"Morbid Mortal Week Rep"},{"key":"2023110918362177000_bib14","first-page":"Unit4A 2","article-title":"Genetic manipulation of Neisseria gonorrhoeae","volume":"4","author":"Dillard","year":"2011","journal-title":"Curr Protoc Microbiol"},{"key":"2023110918362177000_bib15","doi-asserted-by":"crossref","first-page":"e0266764","DOI":"10.1371\/journal.pone.0266764","article-title":"Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection","volume":"17","author":"Elhassanny","year":"2022","journal-title":"PLoS ONE"},{"key":"2023110918362177000_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2021.1988945","article-title":"Dithiocarbamates effectively inhibit the \u03b1-carbonic anhydrase from Neisseria gonorrhoeae","volume":"37","author":"Giovannuzzi","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2023110918362177000_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.ampbs.2022.01.002","article-title":"Neisseria gonorrhoeae physiology and pathogenesis","volume":"80","author":"Green","year":"2022","journal-title":"Adv Microb Physiol"},{"key":"2023110918362177000_bib18","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.1901398","article-title":"Therapeutic CMP-nonulosonates against multidrug-resistant Neisseria gonorrhoeae","volume":"204","author":"Gulati","year":"2020","journal-title":"J Immunol"},{"key":"2023110918362177000_bib19","doi-asserted-by":"crossref","first-page":"e1005290","DOI":"10.1371\/journal.ppat.1005290","article-title":"Utilizing CMP-sialic acid analogs to unravel Neisseria gonorrhoeae lipooligosaccharide-mediated complement resistance and design novel therapeutics","volume":"11","author":"Gulati","year":"2015","journal-title":"PLoS Pathog"},{"key":"2023110918362177000_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acsinfecdis.1c00055","article-title":"Structure\u2013activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae","volume":"7","author":"Hewitt","year":"2021","journal-title":"ACS Infect Dis"},{"key":"2023110918362177000_bib21","doi-asserted-by":"crossref","first-page":"e00892","DOI":"10.1128\/mBio.00892-13","article-title":"Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men","volume":"4","author":"Hobbs","year":"2013","journal-title":"mBio"},{"key":"2023110918362177000_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2011.00123","article-title":"Experimental gonococcal infection in male volunteers: cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC","volume":"2","author":"Hobbs","year":"2011","journal-title":"Front Microbiol"},{"key":"2023110918362177000_bib23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fmicb.2020.01395","article-title":"Neisseria gonorrhoeae NGO2105 is an autotransporter protein involved in adhesion to human cervical epithelial cells and in vivo colonization","volume":"11","author":"Huang","year":"2020","journal-title":"Front Microbiol"},{"key":"2023110918362177000_bib24","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1128\/IAI.70.5.2549-2558.2002","article-title":"Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal lactobacilli","volume":"70","author":"Jerse","year":"2002","journal-title":"Infect Immun"},{"key":"2023110918362177000_bib25","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","article-title":"Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice","volume":"67","author":"Jerse","year":"1999","journal-title":"Infect Immun"},{"key":"2023110918362177000_bib26","first-page":"68","article-title":"Emerging trends in antibiotic resistant Neisseria gonorrhoeae: a national and Hawai\u2018i perspective","volume":"79","author":"Katz","year":"2020","journal-title":"Hawai'i J Health Soc Welfare"},{"key":"2023110918362177000_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40265-021-01530-0","article-title":"Epidemiology, treatments, and vaccine development for antimicrobial-resistant Neisseria gonorrhoeae: current strategies and future directions","volume":"81","author":"Lin","year":"2021","journal-title":"Drugs"},{"key":"2023110918362177000_bib28","doi-asserted-by":"crossref","first-page":"e01570","DOI":"10.1128\/spectrum.01570-22","article-title":"Emergence and genomic characterization of Neisseria gonorrhoeae isolates with high levels of ceftriaxone and azithromycin resistance in Guangdong, China, from 2016 to 2019","volume":"10","author":"Lin","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2023110918362177000_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00430-019-00651-4","article-title":"Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century","volume":"209","author":"M\u0142ynarczyk-Bonikowska","year":"2020","journal-title":"Med Microbiol Immunol"},{"key":"2023110918362177000_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/iai.32.2.641-648.1981","article-title":"Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen","volume":"32","author":"Nachamkin","year":"1981","journal-title":"Infect Immun"},{"key":"2023110918362177000_bib31","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/ijms22052427","article-title":"N-(1, 3, 4-oxadiazol-2-yl) benzamides as antibacterial agents against Neisseria gonorrhoeae","volume":"22","author":"Naclerio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023110918362177000_bib32","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/AAC.46.9.3020-3025.2002","article-title":"Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae","volume":"46","author":"Ng","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110918362177000_bib33","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110918362177000_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2023110918362177000_bib35","first-page":"170","article-title":"Mouse models of human diseaseAn evolutionary perspective","volume":"2016","author":"Perlman","year":"2016","journal-title":"Evol Med Pub Health"},{"key":"2023110918362177000_bib36","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/AEM.07871-11","article-title":"New complementation constructs for inducible and constitutive gene expression in Neisseria gonorrhoeae and Neisseria meningitidis","volume":"78","author":"Ramsey","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"2023110918362177000_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-4939-9496-0_24","article-title":"Female mouse model of Neisseria gonorrhoeae infection","volume-title":"Neisseria gonorrhoeae: Methods and Protocols","author":"Raterman","year":"2019"},{"key":"2023110918362177000_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"2023110918362177000_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijsu.2019.10.015","article-title":"The current state of animal models in research: a review","volume":"72","author":"Robinson","year":"2019","journal-title":"Int J Surg"},{"key":"2023110918362177000_bib40","doi-asserted-by":"crossref","first-page":"e02206","DOI":"10.1128\/AAC.02206-19","article-title":"Repurposing fenamic acid drugs to combat multidrug-resistant Neisseria gonorrhoeae","volume":"64","author":"Seong","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110918362177000_bib1","article-title":"Animal models in drug discovery","author":"Taconic","year":"2019"},{"key":"2023110918362177000_bib41","doi-asserted-by":"crossref","first-page":"110172","DOI":"10.1016\/j.jtbi.2020.110172","article-title":"Identification of potential therapeutic targets in Neisseria gonorrhoeae by an in-silico approach","volume":"490","author":"Tanwer","year":"2020","journal-title":"J Theor Biol"},{"key":"2023110918362177000_bib42","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N Engl J Med"},{"key":"2023110918362177000_bib43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cid\/ciy145","article-title":"Gepotidacin for the treatment of uncomplicated urogenital gonorrhea: a phase 2, randomized, dose-ranging, single-oral dose evaluation","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023110918362177000_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/14728214.2015.1039981","article-title":"Future treatment of gonorrhoea\u2013novel emerging drugs are essential and in progress?","volume":"20","author":"Unemo","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"2023110918362177000_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/AAC.02093-13","article-title":"First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea?","volume":"58","author":"Unemo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110918362177000_bib45","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/jac\/dkw288","article-title":"The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization","volume":"71","author":"Unemo","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2023110918362177000_bib46","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Fut Microbiol"},{"key":"2023110918362177000_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2023110918362177000_bib48","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/jcb.30271","article-title":"Antimicrobial-resistant Neisseria gonorrhoeae can be targeted using inhibitors against evolutionary conservedl-asparaginase","volume":"123","author":"Vashishtha","year":"2022","journal-title":"J Cell Biochem"},{"key":"2023110918362177000_bib49","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med"},{"key":"2023110918362177000_bib50","first-page":"354","volume-title":"Antimicrobial Resistance in Gonorrhoea: What is the Way Forward?","author":"Yarwood","year":"2022"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/femspd\/advance-article-pdf\/doi\/10.1093\/femspd\/ftad030\/52240905\/ftad030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femspd\/article-pdf\/doi\/10.1093\/femspd\/ftad030\/52985837\/ftad030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femspd\/article-pdf\/doi\/10.1093\/femspd\/ftad030\/52985837\/ftad030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T18:36:55Z","timestamp":1699555015000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/ftad030\/7321571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftad030","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023]]},"published":{"date-parts":[[2023]]},"article-number":"ftad030"}}